The DA-EPOCH-R clinical trial in Burkitt's lymphoma
Jeremy Abramson, MD, from the Massachusetts General Hospital, Massachusetts, MA, gives an overview of the interim analysis of a multicenter prospective Phase II study of Dose-Adjusted EPOCH-R (NCT0109...
Author: EMJ
Added: 03/08/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 8, 2016 Category: Cancer & Oncology Source Type: podcasts
The EPOCH-R clinical trial in Burkitt's lymphoma
Jeremy Abramson, MD, from the Massachusetts General Hospital, Massachusetts, MA gives an overview of the preliminary data being presented at the American Society of Hematology (ASH) 2015 Annual Meetin...
Author: VJHemOnc
Added: 02/04/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2016 Category: Cancer & Oncology Source Type: podcasts
TWiV 374: Discordance in B
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler
The TWiVniks consider the role of a cell enzyme that removes a protein linked to the 5'-end of the picornavirus genome, and the connection between malaria, Epstein-Barr virus, and endemic Burkitt's lymphoma.
Links for this episode
Divergent requirements for removing VPg (mBio)
Bond, covalent bond (TWiV 210)
Link between malaria and endemic Burkitt's lymphoma (PLoS Path)
Multifactorial role of malaria in Burkitt's lymphoma (PLoS Path)
Plasmodium infection promotes AID-dependent B cell lymphoma (Cell)
Children's cance...
Source: This Week in Virology - MP3 Edition - January 31, 2016 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
